| No images? Click here 10 October 2025 | Issue 325 Displaced Palestinian in a refugee camp in Gaza's southern city of Rafah, May 2024. © WHO 12 to 14 October 2025 WHO at the World Health Summit in Berlin Emergency and pandemic preparedness and response, digital health and the importance of stronger collaboration in global health at a time of immense change are among key subjects that WHO senior leadership will be addressing during this annual event. https://www.worldhealthsummit.org/events/annual-whs Monday, 13 October Global Antibiotic Resistance Surveillance Report 2025 On 13 October, the World Health Organization (WHO) will release its Global Antibiotic Resistance Surveillance Report 2025, with the latest antibiotic resistance prevalence estimates for 22 antibiotics used to treat four major infection types—urinary tract, bloodstream, gastrointestinal and gonorrhoea. The report covers 8 common bacterial pathogens – Acinetobacter spp., Escherichia coli, Klebsiella pneumoniae, Neisseria gonorrhoeae, non-typhoidal Salmonella spp., Shigella spp., Staphylococcus aureus and Streptococcus pneumoniae — each linked to one or more of these infections. The report is available to journalists under embargo; please write to mediainquiries@who.int to request a copy. The official launch will be in a webinar at 13.00 CEST on Monday, 13 October. For further information and registrations, please see here. ********** Launch of WHO’s upgraded public health intelligence system 14.30 to 15.30 CEST, hybrid (WHO Hub for Pandemic and Epidemic Intelligence, Berlin, Germany and livestreamed) On 13 October, WHO will launch version 2.0 of the Epidemic Intelligence from Open Sources (EIOS) system, used globally for the early detection of public health threats. Hosted at the WHO Hub for Pandemic and Epidemic Intelligence in Berlin, EIOS is the world’s leading initiative for open-source intelligence for public health decision-making used by more than 110 Member States and around 30 organizations and networks. During the event, the first prototype of the Pandemic Simulator will also be unveiled, another innovative tool to strengthen preparedness and response to health crises. Embargoed access to the press release and interviews are available on request. Please write to gilbertzs@who.int with a copy to mediainquiries@who.int. Further information and registration for in-person attendance: here. Watch the livestream here. Tuesday, 14 October 11 million lives lost each year: urgent action needed on neurological care In its landmark Global status report on neurology, to be released on 14 October, WHO provides estimates of number of deaths caused by neurological disorders, as well as the global burden of neurological conditions. The report also warns that less than one in three countries around the world have a national policy to address the growing burden of disorders. The report and the accompanying press release are available to journalists under embargo, which will lift at 10.30 CEST / 08.30 GMT on Tuesday, 14 October. Please request your copy at levind@who.int with a copy to mediainquiries@who.int. 14 to 16 October Eighth global Eliminate Yellow Fever Epidemics (EYE) strategy annual partners’ meeting 2025 The EYE Strategy is a comprehensive, multi-component, and multi-partner initiative aimed at eliminating yellow fever (YF) epidemics globally by the end of 2026. It is anchored on three strategic objectives: Protect at-risk populations, Prevent international spread, and Contain outbreaks rapidly. The meeting will focus on the challenges faced by countries and partners, how to best address them, the overall impact on EYE Strategy implementation and timelines, the transition and sustainability phase, and the way forward in integration with relevant initiatives on the vector, vaccine, urban and occupational components of the programme. Further information and registration: here. Thursday, 16 October Country Voices on Trans Fat Elimination: Policies in Action 10.00 to 11.00 CEST, virtual In 2018, WHO released the REPLACE action framework for trans fat elimination and subsequently its six modules, to support Member States to eliminate industrially produced trans fats from their national food supplies and to replace these with healthier oils and fats. Today, more than sixty countries have passed policies to eliminate trans fats from their food supplies and protect their populations. Each country’s path to eliminating industrially produced trans fats is shaped by its unique food supply structure, key dietary sources of trans fat, available resources, and broader regulatory environment. Despite these differences, valuable lessons can be drawn from country experiences to inform and inspire action in similar national contexts. This webinar will spotlight the experiences of three countries from different regions and regulatory settings. Speakers will share insights into the challenges faced, solutions implemented, and key takeaways in introducing, monitoring, and enforcing trans fat elimination policies. Further information and registration: here. ******************* Public consultation on the COP30 Special Report on “Social Participation” for the implementation of the Belém Health Action Plan 14.00 to 15.00 CEST, virtual In the run up to COP30, WHO in collaboration with the Ministry of Health (MoH) Brazil invite you to participate in a public consultation for a preview of a supporting document for the Belém Health Action Plan – the Special Report on “Social Participation” for Implementation. This consultation will continue to collect ideas and examples after COP30 through to Bonn, showcasing diverse forms of social participation by civil society, NGOs, social movements, and other initiatives that advance climate and health action globally. Further information and registration: here. WHO events here Sign up for our newsletters here Check out the WHO series, Science in 5 Catch a series that debunks misinformation around WHO and public health, Plot Twist Access WHO photos available for media use here WHO media contacts: You are receiving this NO-REPLY email because you are included on a WHO mail list. |


0 Comments